diagnostics

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA biomarkers

Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home Alzheimer’s blood collection

Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Abbott to acquire Exact Sciences

Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG

Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG Professional…

by Timos Papagatsias

Onco_background

Oncology Weekly News - September 22nd 2025

Oncology Update: RGT-61159 Orphan Drug, CRB-701 Fast Track, PDS0101 Survival…

by LucidQuest

ELCC 2025_Preview_by_LucidQuest

ELCC 2025 Preview: Key Lung Cancer Highlights to Watch

ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.